≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Deficiency of other B group vitamins

DOID EFO Endpoint Browser PheWeb

E4_VIT_B_DEF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E53
  • Hospital discharge: ICD-9 — 266
  • Hospital discharge: ICD-8 — 264
  • Cause of death: ICD-10 — E53
  • Cause of death: ICD-9 — 266
  • Cause of death: ICD-8 — 264
  • KELA reimbursements: KELA codes — ANY
  • KELA reimbursements: ICD-10 — E53.8

3 out of 7 registries used, show all original rules.

783

4. Check minimum number of events

None

783

5. Include endpoints

None

783

6. Filter based on genotype QC (FinnGen only)

783

Control definitions (FinnGen only)

Control exclude
E4_NUTRIDEF

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E50-E64
Name in latin
Deficientia aliorum vitaminorum B

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4877 2712 2110
Only index persons 3881 2214 1667
Unadjusted period prevalence (%)
Whole population 0.07 0.08 0.06
Only index persons 0.07 0.08 0.06
Median age at first event (years)
Whole population 73.31 74.06 72.33
Only index persons 72.05 72.65 71.25

-FinnGen-

Key figures

All Female Male
Number of individuals 783 442 341
Unadjusted period prevalence (%) 0.15 0.15 0.15
Median age at first event (years) 61.90 56.54 68.84

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
721
Matched controls
7208
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
880.7
323.0
353
8
107
Kela drug reimbursment
Pernicious anaemia
125.6
323.0
391
67
B03BA03
ATC
hydroxocobalamin; parenteral
80.9
323.0
519
221
B81
ICPC
Anaemia vit B12/folate deficiency
46.1
264.0
328
128
K29.4
ICD-10 Finland
Chronic atrophic gastritis
27.1
102.2
143
65
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.8
81.1
381
1362
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
25.2
53.1
75
33
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
28.8
45.0
61
23
E53.9
ICD-10 Finland
Vitamin B deficiency, unspecified
464.8
44.7
44
*
E66.8
ICD-10 Finland
Other obesity
55.8
44.2
52
10
E66.01
ICD-10 Finland
Obesity due to excess calories
25.1
41.2
58
25
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
+∞
32.5
31
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
28.2
307
1640
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.4
27.3
353
2053
T91
ICPC
Vitamin/nutritional deficiency
25.0
27.2
38
16
B03BA01
ATC
cyanocobalamin; nasal, systemic
78.2
27.0
30
*
E66.9
ICD-10 Finland
Obesity, unspecified
32.3
26.1
34
11
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.3
26.0
102
264
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
18.7
22.4
34
19
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.2
21.8
124
433
H03AA01
ATC
levothyroxine sodium; systemic
2.5
20.9
204
993
-50
ICPC
Medication/prescr/renewal
5.4
20.9
64
127
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
113.2
20.7
22
*
UJF32
NOMESCO Finland
Coloscopy
2.3
18.8
219
1156
2662A
ICD-9 Finland
Deficiency of B-complex components, Other B-complex deficiencies[HYPOVITAMINOSIS B12]
+∞
18.8
18
*
E66.00
ICD-10 Finland
Metabolic syndrome
12.7
18.7
33
27
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
18.1
279
1664
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
17.7
98
335
K50.0
ICD-10 Finland
Crohn disease of small intestine
10.1
17.3
34
35
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
13.7
17.1
29
22
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
16.7
334
2192
A10AE04
ATC
insulin glargine; parenteral
3.4
16.5
85
276
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
16.4
109
421
A02BC02
ATC
pantoprazole; systemic
1.9
16.0
470
3536
WVA30
SPAT
NA
6.4
15.7
41
67
SPAT1254
SPAT
Administration of medicine
2.4
15.2
142
664
N03AX16
ATC
pregabalin; oral
2.2
15.2
188
1005
R4190
NOMESCO Finland
Nutritional therapy
6.9
15.0
37
56
N02AX02
ATC
tramadol; systemic, rectal
1.9
14.7
321
2144
K50.8
ICD-10 Finland
Other Crohn disease
8.7
14.6
31
37
A55
ICPC
General and Unspecified, Local injection/infiltration
11.2
14.6
27
25
RD210
NOMESCO Finland
NA
10.7
14.3
27
26
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
14.3
126
569
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.1
14.3
45
93
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
13.8
98
392
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
13.8
171
910
A07EA06
ATC
budesonide; oral, local oral
5.0
13.4
43
91
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
12.9
171
933
K50.9
ICD-10 Finland
Crohn disease, unspecified
8.5
12.6
27
33
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
12.3
238
1495
C10AC01
ATC
colestyramine; oral
5.1
12.2
38
78
D51
ICD-10 Finland
Vitamin B12deficiency anaemia
15.0
11.8
19
13
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
11.8
198
1179
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
11.7
175
1000
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.2
11.7
44
110
C03CA01
ATC
furosemide; systemic
1.8
11.6
252
1643
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.0
11.6
46
121
F02.89*E53.8
ICD-10 Finland
Dementia due to vitamin B12 deficiency
+∞
11.5
11
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
11.3
65
228
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
11.3
166
939
R42
ICD-10 Finland
Dizziness and giddiness
2.0
11.2
176
1021
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.3
11.1
40
96
B82
ICPC
Anaemia other/unspecified
5.3
11.0
33
65
A10BA02
ATC
metformin; oral
1.9
10.8
198
1215
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
10.7
78
317
376
Kela drug reimbursment
Cyanocobalamin
60.9
10.6
12
*
K29.7
ICD-10 Finland
Gastritis, unspecified
4.0
10.6
42
111
G32.0*E53.8
ICD-10 Finland
Subacute combined degeneration of the spinal cord in case of vitamin B12 deficiency
+∞
10.4
10
*
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
+∞
10.4
10
*
A06AD11
ATC
lactulose; oral
2.1
10.4
135
724
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
16.3
10.4
16
10
B80
ICPC
Iron deficiency anaemia
5.4
10.4
30
57
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
10.3
129
682
N05AH04
ATC
quetiapine; oral
2.2
10.3
115
580
L04AX01
ATC
azathioprine; systemic
3.5
10.2
46
136
N06AB04
ATC
citalopram; systemic
1.9
10.0
162
947
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
9.8
212
1368
104
Kela drug reimbursment
Thyroid insufficiency
2.7
9.8
68
269
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
9.7
123
655
N06AX11
ATC
mirtazapine; oral
1.8
9.7
221
1445
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
9.7
50
164
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.2
9.6
18
18
XF402
NOMESCO Finland
ECG with work load test
2.3
9.5
87
399
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.9
9.4
38
102
QBJ30
NOMESCO Finland
Correction of abdominal apron
30.4
9.4
12
*
E66.0
ICD-10 Finland
Obesity due to excess calories
+∞
9.4
9
*
E61.2
ICD-10 Finland
Magnesium deficiency
+∞
9.4
9
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
12.5
9.4
16
13
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.4
124
671
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
9.3
195
1241
SPAT1262
SPAT
Handing over of treatment supplies
2.0
9.3
129
711
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
9.3
101
502
R4110
NOMESCO Finland
Physiotherapy
1.8
9.2
187
1176
R11
ICD-10 Finland
Nausea and vomiting
2.7
9.2
64
252
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
9.2
90
429
K50.1
ICD-10 Finland
Crohn disease of large intestine
7.6
9.0
20
27
N06AX16
ATC
venlafaxine; oral
2.2
9.0
91
440
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
8.9
111
584
WX110
NOMESCO Finland
Local anesthesy
1.6
8.9
426
3402
T90
ICPC
Diabetes non-insulin dependent
1.9
8.7
150
893
A28
ICPC
Limited function/disability NOS
2.0
8.7
126
704
H02AB06
ATC
prednisolone; systemic
1.6
8.7
329
2468
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
8.7
131
743
K90.0
ICD-10 Finland
Coeliac disease
5.2
8.5
25
49
JFB00
NOMESCO Finland
Partial resection of small intestine
5.8
8.5
23
41
A07AA02
ATC
nystatin; oral
2.7
8.4
56
216
P01AB01
ATC
metronidazole; oral, rectal
1.6
8.3
266
1901
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
8.3
62
255
-55
ICPC
Local injection/infiltration
7.7
8.2
18
24
A01
ICPC
Pain general/multiple sites
2.4
8.1
67
291
M25.5
ICD-10 Finland
Pain in joint
1.7
8.1
180
1160
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.1
592
5218
N06AX21
ATC
duloxetine; oral
2.4
8.1
70
313
N06AA09
ATC
amitriptyline; systemic
2.2
8.1
78
369
UJF92
NOMESCO Finland
Capsular endoscopy
5.4
8.0
23
44
D07AA02
ATC
hydrocortisone; topical
2.1
7.9
92
472
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
7.9
206
1392
SPAT1216
SPAT
Assessment of functional ability
1.9
7.8
125
723
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
7.8
65
285
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
7.7
122
702
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
7.6
56
230
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
18.6
7.6
11
6
J01MA12
ATC
levofloxacin; systemic
1.8
7.6
138
835
N06AB03
ATC
fluoxetine; oral
2.1
7.5
85
429
TAB00
NOMESCO Finland
Lumbar puncture
3.2
7.5
38
124
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.2
7.5
17
24
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.1
7.5
39
130
R53
ICD-10 Finland
Malaise and fatigue
1.8
7.5
151
942
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
7.5
288
2145
R25.1
ICD-10 Finland
Tremor, unspecified
4.0
7.4
28
72
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.0
7.4
28
72
D51.8
ICD-10 Finland
Other vitamin B12deficiency anaemias
13.5
7.4
12
9
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
7.4
136
827
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.4
7.3
60
261
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
7.3
43
155
E0000UV
ATC
NA
1.6
7.3
260
1896
JAH01
NOMESCO Finland
Laparoscopy
3.2
7.3
37
121
E53.1
ICD-10 Finland
Pyridoxine deficiency
+∞
7.3
7
*
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
+∞
7.3
7
*
A07EC02
ATC
mesalazine; oral, rectal
2.9
7.2
42
150
L28
ICPC
Limited function/disability (L)
1.8
7.2
125
741
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.2
139
854
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
7.2
56
238
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.2
7.2
76
374
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.6
7.2
30
85
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.1
264
1939
ZX120
NOMESCO Finland
Intravenous
2.2
7.1
75
367
T82
ICPC
Obesity
4.8
7.1
22
47
A10BB12
ATC
glimepiride; oral
2.3
7.0
63
286
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
7.0
225
1600
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.9
176
1174
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.7
6.8
28
78
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.8
289
2187
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.7
6.8
18
32
M04AA01
ATC
allopurinol; systemic
1.9
6.8
99
554
WZC30
NOMESCO Finland
Teaching
2.0
6.7
89
481
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
6.7
188
1288
R06.0
ICD-10 Finland
Dyspnoea
1.6
6.7
170
1135
R06AE07
ATC
cetirizine; oral
1.5
6.6
267
1997
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
6.6
68
332
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
4.9
6.6
20
42
R51.80
ICD-10 Finland
Headache
2.0
6.6
88
477
R03AC02
ATC
salbutamol; inhalant
1.5
6.6
324
2534
A10BG03
ATC
pioglitazone; oral
4.2
6.5
23
56
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
6.5
147
948
A10BH01
ATC
sitagliptin; oral
2.2
6.5
65
313
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.8
6.4
20
43
A04
ICPC
Weakness/tiredness general
1.9
6.4
96
542
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.4
166
1111
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.4
66
322
T89
ICPC
Diabetes insulin dependent
3.6
6.4
27
78
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
6.4
85
462
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
8.2
6.3
13
16
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
5.6
6.3
17
31
B50
ICPC
Blood and Immunity, Medication/prescr/renewal
11.1
6.3
11
10
D52.9
ICD-10 Finland
Folate deficiency anaemia, unspecified
26.9
6.2
8
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
6.2
55
249
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.4
6.1
52
230
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
6.1
230
1685
K08.3
ICD-10 Finland
Retained dental root
2.4
6.1
49
211
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.1
6.1
31
103
E000001
ATC
NA
1.7
6.1
140
907
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
6.1
182
1264
J45
ICD-10 Finland
Asthma
2.2
6.1
60
289
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
6.0
28
87

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
502
2510
3.79
70.89
3.2
2.0
pmol/l
82.5
93.6
4.61
313
1273
(3019309) Folate [Moles/volume] in Red Blood Cells
314
1252
3.52
61.38
2.1
1.7
nmol/l
1131.6
1162.1
0.22
251
919
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
346
1616
3.04
49.72
3.0
2.1
mg/l
3.0
3.0
0.01
300
1375
(3004789) Transferrin [Mass/volume] in Serum or Plasma
217
860
3.11
40.44
3.1
2.3
g/l
2.4
2.3
1.02
208
790
(3022948) Iron [Moles/volume] in Serum or Plasma
229
944
3.02
39.73
3.2
2.3
umol/l
12.1
12.8
0.76
222
868
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
424
2412
2.65
39.14
3.6
2.2
nmol/l
75.3
79.0
1.63
373
2131
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
204
800
3.10
38.53
3.2
2.3
%
21.2
22.2
0.43
184
680
(40768797) Stomach Pathology biopsy report
202
800
3.06
37.39
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
486
3024
2.60
36.19
8.8
6.3
mmol/l
1.2
1.2
2.15
420
2522
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
279
1332
2.70
36.18
2.3
1.7
pmol/l
38053553.4
23389022.2
0.15
226
1086
(3003458) Phosphate [Moles/volume] in Serum or Plasma
188
739
3.03
35.04
5.1
5.0
mmol/l
1.0
1.0
0.30
179
664
(3024561) Albumin [Mass/volume] in Serum or Plasma
432
2600
2.48
33.68
6.4
4.3
g/l
34.4
35.2
2.27
406
2392
(3021960) Folate [Moles/volume] in Serum or Plasma
295
1510
2.53
32.50
2.2
1.6
nmol/l
18.0
21.1
2.98
260
1279
(3012095) Magnesium [Moles/volume] in Serum or Plasma
211
916
2.78
32.49
4.0
3.2
mmol/l
0.8
0.8
1.97
200
849
(3001122) Ferritin [Mass/volume] in Serum or Plasma
426
2577
2.43
32.42
4.9
2.6
ug/l
115.1
128.1
0.63
397
2350
(42870588) Differential panel, method unspecified - Blood
339
1897
2.39
30.19
7.2
5.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
420
2620
2.30
28.52
7.6
5.6
%
0.6
0.7
0.25
389
2423
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
433
2756
2.28
27.75
8.5
5.6
mmol/l
1.2
1.2
1.22
404
2477
(3019069) Monocytes/100 leukocytes in Blood
427
2703
2.28
27.72
8.0
5.8
%
8.6
8.7
0.13
397
2509
(3006504) Eosinophils/100 leukocytes in Blood
425
2693
2.26
27.42
7.7
5.5
%
2.8
2.8
0.06
394
2487
(3018010) Neutrophils/100 leukocytes in Blood
426
2721
2.24
26.71
7.6
5.5
%
58.7
57.8
0.67
397
2527
(3002030) Lymphocytes/100 leukocytes in Blood
429
2757
2.23
26.37
7.9
5.7
%
26.3
27.2
0.85
400
2544
(3013115) Eosinophils [#/volume] in Blood
454
2991
2.23
26.16
7.7
5.7
e9/l
0.2
0.2
0.36
400
2639
(3006315) Basophils [#/volume] in Blood
441
2879
2.22
25.90
7.6
5.4
e9/l
0.0
0.0
0.04
382
2497
(3019198) Lymphocytes [#/volume] in Blood
447
2935
2.22
25.86
7.7
5.4
e9/l
1.8
1.9
0.81
401
2601
(3001604) Monocytes [#/volume] in Blood
438
2861
2.20
25.57
7.7
5.3
e9/l
0.6
0.6
0.42
378
2473
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
319
1853
2.22
24.82
3.2
2.4
u/l
54.9
58.3
0.81
294
1718
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
462
3120
2.17
24.30
7.2
5.9
umol/l
11.0
11.6
0.58
435
2953
(3048689) Calprotectin [Mass/mass] in Stool
152
640
2.71
24.21
3.8
2.1
ug/g
164.2
118.4
1.07
122
507
(3013650) Neutrophils [#/volume] in Blood by Automated count
477
3373
2.06
20.83
11.1
8.7
e9/l
4.5
4.2
1.73
422
2960
(3013826) Glucose [Moles/volume] in Serum or Plasma
486
3483
2.04
20.16
6.9
4.6
mmol/l
6.9
6.7
1.05
470
3270
(3006653) Thiamine [Moles/volume] in Blood
22
21
10.75
20.08
2.3
1.1
nmol/l
117.2
127.1
0.35
22
21
(3027945) Reticulocytes/100 erythrocytes in Blood
156
730
2.42
19.64
2.8
2.4
%
1.7
1.8
0.47
130
647
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
120
505
2.63
18.87
3.1
2.1
g/l
0.2
0.2
1.88
115
467
(3036481) Cortisol [Moles/volume] in Serum or Plasma
120
523
2.53
17.50
1.6
2.0
nmol/l
408.7
383.8
0.54
107
479
(3019225) pH of Specimen
128
577
2.46
17.36
5.4
4.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
583
4594
2.05
16.96
11.1
7.1
u/l
86.9
78.7
2.09
553
4284
(3020779) Urea [Moles/volume] in Serum or Plasma
115
502
2.51
16.68
6.0
6.4
mmol/l
9.8
10.5
0.44
106
473
(3037522) Nuclear Ab [Titer] in Serum
146
711
2.29
16.59
1.5
1.3
titre
521.3
519.0
0.00
31
162
(3032080) INR in Blood by Coagulation assay
368
2510
1.88
16.39
11.0
10.4
inr
1.3
1.3
0.08
96
707
(3023520) Reticulocytes [#/volume] in Blood
118
529
2.45
16.15
3.1
2.4
e9/l
64.7
68.5
0.61
94
423
(3037467) Urinalysis macro (dipstick) panel - Urine
531
4102
1.92
15.69
5.7
4.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
559
4404
1.94
15.40
5.5
4.0
mm/h
14.4
12.9
1.42
519
4016
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
211
1218
2.00
15.33
1.3
1.2
u/ml
2.6
1.4
0.32
50
321
(3007164) IgA [Mass/volume] in Serum or Plasma
187
1041
2.05
14.99
1.8
1.5
g/l
2.5
2.5
0.08
92
617
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
102
442
2.50
14.97
1.9
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
104
456
2.48
14.89
3.5
3.6
ng/l
81.3
87.6
0.35
81
398
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
284
1831
1.86
14.71
2.3
2.1
u/l
203.9
245.8
0.18
273
1714
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
136
680
2.21
14.37
3.6
3.9
u/l
236.0
241.7
0.18
127
642
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
283
1840
1.84
14.15
3.6
3.1
u/l
45.8
33.1
0.51
269
1754
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
133
664
2.21
14.09
3.0
2.5
umol/l
7.2
7.9
0.19
118
576
(3014576) Chloride [Moles/volume] in Serum or Plasma
143
735
2.16
14.09
8.4
6.3
mmol/l
105.0
104.3
0.87
143
715
(3044640) Blood type and Crossmatch panel - Blood
285
1868
1.83
13.81
3.1
2.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
85
354
2.57
13.53
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
98
437
2.42
13.49
3.2
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
265
1709
1.83
13.47
4.9
4.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
162
3.30
13.24
1.4
1.5
ug/g
315.2
272.0
0.63
25
95
(3007853) Bacteria identified in Skin by Aerobe culture
130
662
2.16
13.06
1.9
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
107
507
2.29
12.81
7.9
6.2
mmol/l
1.5
1.4
0.24
101
482
(3020630) Protein [Mass/volume] in Serum or Plasma
107
516
2.24
12.27
3.3
2.9
g/l
66.0
66.3
0.21
94
469
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
74
4.32
12.08
1.3
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
76
324
2.49
11.50
2.8
2.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
121
630
2.09
11.40
1.6
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
79
347
2.42
11.21
5.2
3.8
mmol/l
1.1
1.9
0.94
61
264
(40758558) Short blood count panel - Blood
226
1456
1.78
11.17
7.7
6.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
57
216
2.77
10.91
5.4
4.4
mmol/l
24.4
25.0
0.71
52
204
(3015377) Calcium [Moles/volume] in Serum or Plasma
300
2104
1.69
10.87
3.5
3.3
mmol/l
2.3
2.4
3.73
258
1822
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
85
3.88
10.85
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
217
1395
1.77
10.75
3.1
2.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
86
400
2.29
10.72
3.1
3.0
g/l
10.2
10.5
0.23
75
363
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
161
946
1.88
10.69
1.4
1.3
iu/ml
26.3
35.9
0.73
45
309
(3009343) pH of Capillary blood
81
368
2.34
10.65
5.3
3.8
ph
7.4
7.4
0.51
11
44
(3017143) Hepatitis C virus Ab [Presence] in Serum
102
513
2.14
10.49
1.5
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
101
507
2.14
10.44
3.2
2.3
u/l
34.7
32.7
0.16
87
424
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
81
373
2.31
10.33
5.3
3.8
kpa
5.1
5.1
0.07
76
346
(3002032) Base excess in Venous blood by calculation
109
567
2.07
10.26
3.8
3.4
mmol/l
1.5
1.8
0.30
87
447
(3002582) Erythrocytes [#/volume] in Urine
271
1874
1.68
10.22
3.9
3.3
e6/l
82.3
111.7
0.21
211
1457
(3018418) pH of Serum or Plasma
268
1849
1.68
10.19
5.8
3.7
ph
7.4
7.4
0.15
48
348
(3000991) Gas panel - Venous blood
95
471
2.16
10.13
9.6
7.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
280
2.48
10.09
1.7
1.8
g/l
1.4
1.5
0.40
50
249
(3004616) Nuclear Ab [Presence] in Serum
27
67
4.14
10.03
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
280
1964
1.66
9.94
3.9
3.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
158
2.96
9.91
1.2
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
304
2188
1.64
9.70
4.2
3.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
143
847
1.84
9.16
17.0
26.8
inr
1.2
1.3
0.25
16
114
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
105
561
2.01
9.16
2.0
1.6
%
1.6
1.5
0.69
87
482
(3034860) Kappa light chains.free [Mass/volume] in Serum
50
195
2.67
9.08
4.7
3.8
mg/l
55.2
88.4
0.49
39
156
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
324
2397
1.60
9.08
4.7
3.8
ng/l
39.3
44.4
0.18
244
1719
(3018095) Leukocytes [#/volume] in Urine
299
2171
1.61
9.05
4.7
3.7
e6/l
143.5
128.9
0.09
218
1572
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
163
1011
1.77
8.95
2.2
1.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
36
118
3.15
8.92
1.1
1.2
u/ml
1.6
1.0
—
5
7
(3022313) Gas panel - Capillary blood
62
271
2.40
8.90
5.0
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
73
346
2.22
8.69
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
42
153
2.84
8.68
1.3
1.2
u/ml
1.6
7.1
0.88
11
24
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
23
57
4.13
8.57
1.3
1.1
u/l
63.1
57.5
0.24
12
41
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
195
2.61
8.56
4.8
3.8
mg/l
41.6
47.2
0.13
38
156
(3028026) IgM [Mass/volume] in Serum or Plasma
67
310
2.27
8.45
2.5
1.8
g/l
1.3
1.6
0.41
59
280
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
265
1903
1.59
8.23
3.2
3.1
ng/l
1565.8
1680.7
0.19
229
1647
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
36
124
2.99
8.22
1.1
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
189
1249
1.68
8.19
3.6
2.8
mosm/kgh2o
550.8
553.1
0.05
158
1060
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
358
2756
1.55
8.19
4.6
4.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
535
4506
1.59
8.18
5.6
3.9
pmol/l
15.2
14.8
2.34
471
4040
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
660
5867
1.80
8.14
24.9
14.6
mg/l
26.3
25.1
0.31
572
4638
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
111
629
1.89
8.13
1.5
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
216
1489
1.62
7.90
2.8
2.6
umol/l
8867.7
8474.5
0.03
182
1263
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
40
150
2.76
7.85
1.3
1.2
u/ml
1.1
2.7
—
7
17
(3030467) Casts [#/volume] in Urine by Automated count
241
1710
1.59
7.80
3.7
3.2
e6/l
0.6
0.5
0.21
186
1298
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
450
3669
1.53
7.75
4.6
2.9
u/l
60.7
47.8
0.80
429
3409
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
125
2.88
7.52
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
46
190
2.51
7.47
3.4
3.2
g/l
0.2
0.3
0.08
27
67
(3009508) Creatinine [Moles/volume] in Urine
242
1735
1.57
7.43
3.3
3.0
mmol/l
7.1
7.1
0.00
196
1427
(3020682) Albumin/Creatinine [Ratio] in Urine
245
1762
1.57
7.42
4.1
3.9
mg/mmol
14.5
9.3
0.59
152
1090
(3035637) Corticotropin [Mass/volume] in Plasma
22
59
3.81
7.39
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
321
2.15
7.39
4.1
3.3
pmol/l
4.2
4.5
2.52
56
281
(3042936) Bacteria identified in Isolate by Culture
139
868
1.73
7.36
2.4
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
360
2.07
7.14
1.9
1.6
—
—
—
0
0
(3013512) EKG study
244
1771
1.55
7.03
5.2
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
365
2890
1.49
6.94
4.5
3.8
estimate
0.0
0.0
0.00
76
540
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
48
210
2.37
6.91
1.9
2.3
ug/l
262.4
472.2
0.43
48
199
(46235355) HIV 1 and 2 tests - Meaningful Use set
124
763
1.74
6.90
1.7
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
148
958
1.67
6.84
3.3
3.0
e6/l
3.0
2.4
0.29
80
542
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
180
2.47
6.81
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
37
144
2.65
6.79
4.9
4.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
14
7.22
6.71
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
41
169
2.50
6.71
2.3
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
176
1198
1.61
6.65
4.1
3.8
ng/l
155.5
326.3
1.09
144
968
(36660697) Celiac disease serology panel - Serum
78
420
1.95
6.64
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
230
1667
1.54
6.61
3.5
3.1
mg/l
617.5
218.9
0.51
152
1040
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
64
3.51
6.60
1.1
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
50
228
2.27
6.56
1.9
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
39
159
2.53
6.53
1.1
1.1
u/ml
13.3
6.4
—
7
18
(3021879) Hepatitis B virus core Ab [Presence] in Serum
64
323
2.07
6.52
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
25
5.27
6.50
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
25
5.27
6.50
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
109
658
1.76
6.47
3.8
4.0
ug/l
10.1
27.7
0.76
91
550
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
25
81
3.16
6.36
2.1
2.0
pg
32.1
32.7
0.30
25
81
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
608
5397
1.57
6.30
6.9
4.7
mu/l
1.9
2.2
0.60
539
4865
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
0
+∞
6.26
2.0
0.0
mg/l
1.2
—
—
6
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
40
169
2.44
6.23
1.5
1.6
iu/ml
0.0
36.5
—
5
33
(3011397) Hemoglobin [Presence] in Urine by Test strip
188
1318
1.56
6.22
4.1
3.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
72
3.26
6.19
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
72
3.26
6.19
1.8
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
182
1271
1.56
6.12
2.1
1.6
mg/l
1.3
1.2
0.24
142
994
(4024509)
18
48
3.81
6.11
1.9
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
364
2931
1.45
6.09
4.8
3.8
estimate
0.0
0.0
0.50
75
528
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
73
3.22
6.06
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
73
3.22
6.06
1.8
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
184
2.36
6.05
1.8
2.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
35
4.35
6.04
1.5
1.5
u/l
5.2
8.3
—
5
18
(3019550) Sodium [Moles/volume] in Serum or Plasma
669
6093
1.67
6.03
27.5
17.1
mmol/l
139.4
139.6
1.50
653
5917
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
63
3.40
6.03
3.0
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
224
1642
1.51
6.02
3.8
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
360
2901
1.45
5.96
6.5
5.1
estimate
0.0
0.0
0.50
77
533
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
74
3.17
5.93
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
74
3.17
5.93
1.8
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
36
4.23
5.84
1.3
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
21
65
3.29
5.76
1.0
1.2
iu/ml
111.8
67.1
—
5
9
(3021589) Normoblasts [#/volume] in Blood
322
2554
1.44
5.74
14.2
9.3
e9/l
0.0
0.0
0.61
254
2093
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
150
1017
1.59
5.70
2.9
2.8
e6/l
1.0
1.1
0.31
84
599
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
114
722
1.68
5.69
4.6
4.4
%
34.9
33.0
0.92
78
472
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
138
918
1.61
5.68
1.4
1.3
u/ml
13.6
12.0
0.08
42
346
(3023103) Potassium [Moles/volume] in Serum or Plasma
668
6106
1.64
5.64
27.7
17.2
mmol/l
4.0
4.0
0.87
649
5918
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
51
250
2.11
5.63
2.1
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
128
2.56
5.60
2.3
2.5
ug/min
189.2
113.2
0.36
21
80
(3018677) aPTT in Platelet poor plasma by Coagulation assay
139
931
1.60
5.55
2.5
1.8
s
30.0
29.6
0.46
133
902
(3003396) Base excess in Arterial blood by calculation
108
682
1.68
5.44
9.7
7.5
mmol/l
0.4
1.3
1.38
91
524
(3000494) Fungus identified in Specimen by Culture
107
680
1.66
5.26
1.6
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
184
1327
1.51
5.26
3.0
2.6
e6/l
5.4
5.8
0.16
154
1170
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
69
3.10
5.25
1.4
1.6
g/l
0.8
0.8
0.06
16
50
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
231
2.10
5.17
3.7
2.0
g/l
3.2
3.1
0.26
36
187
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
44
211
2.15
5.15
4.2
2.2
g/l
0.2
1.1
1.85
38
187
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
30
122
2.52
5.09
1.3
1.2
u/ml
21.2
33.6
—
6
13
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
27
4.50
5.05
1.5
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
23
82
2.86
5.02
1.4
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
36
3.94
5.00
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
131
2.42
4.87
1.5
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
42
3.62
4.78
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
607
5490
1.47
4.78
22.1
13.7
ml/min/173m2
77.5
77.4
0.04
530
4507
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
232
2.04
4.75
3.8
2.0
g/l
10.1
10.5
0.27
36
202
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
246
2.01
4.74
3.7
2.0
g/l
3.9
3.6
0.92
34
183
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
133
2.39
4.72
1.7
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
247
2.00
4.69
3.7
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
247
2.00
4.69
3.7
2.0
g/l
7.3
7.3
0.00
36
191
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
38
3.73
4.66
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
38
3.73
4.66
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
599
5421
1.45
4.55
7.5
5.7
mmol/mol
41.4
39.9
2.28
537
4992
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
168
2.20
4.53
1.8
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
56
308
1.88
4.53
1.4
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
41
203
2.08
4.46
3.7
2.1
g/l
36.6
37.6
0.70
35
174
(3002173) Hemoglobin [Mass/volume] in Arterial blood
88
560
1.64
4.31
10.6
8.4
g/l
118.5
120.3
0.35
88
543
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
8
9
8.97
4.28
1.3
1.0
%
109.1
108.7
—
8
9
(1616796) Gas panel - Central venous blood
27
114
2.42
4.27
6.7
3.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
127
2.33
4.24
1.6
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
73
2.79
4.21
1.1
1.0
u/ml
7.7
1.8
—
5
30
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
64
376
1.76
4.20
2.3
2.4
—
8.8
—
0
11
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
45
236
1.96
4.20
1.4
2.1
u/l
35.0
40.0
1.44
40
207
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
27
4.12
4.17
3.2
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
54
302
1.85
4.16
2.8
2.2
%
0.7
0.7
0.16
54
291
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
47
3.23
4.07
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
58
335
1.79
4.04
1.3
1.3
—
40.0
—
0
18
(3019230) Fractional oxyhemoglobin in Venous blood
25
105
2.43
4.01
1.5
1.9
%
56.0
59.8
0.31
25
105
(3017732) Neutrophils [#/volume] in Blood
63
375
1.74
3.96
3.1
3.1
e9/l
4.1
4.0
0.11
44
284
(3044290) Cell count panel - Cerebral spinal fluid
25
106
2.40
3.94
1.4
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
76
2.67
3.92
1.3
1.4
u/ml
108.3
114.2
—
9
16
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
390
3338
1.34
3.89
3.2
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
84
2.54
3.74
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
25
4.04
3.70
1.1
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
68
423
1.67
3.66
5.7
4.2
%
0.1
0.9
0.53
16
116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
184
2.00
3.64
3.9
2.3
u/ml
0.3
0.4
0.33
19
99
(3036489) Thrombin time
37
192
1.97
3.59
2.3
1.8
s
20.2
21.2
0.91
32
172
(3052851) Hemolysis interference index of Serum or Plasma
35
178
2.01
3.59
2.3
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
292
2419
1.33
3.56
2.4
2.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
17
5.34
3.51
1.0
1.1
miu/ml
965.8
1582.5
—
9
17
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
63
2.74
3.51
1.2
1.2
pmol/l
1296.1
318.1
—
10
50
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
13
6.20
3.50
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
13
6.20
3.50
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
653
6089
1.44
3.49
23.3
13.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
120
862
1.46
3.44
1.7
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
88
2.42
3.42
1.4
7.0
iu/ml
—
150.1
—
0
12
(3012501) Base excess in Blood by calculation
26
120
2.21
3.41
7.0
3.2
mmol/l
2.6
2.6
0.02
17
80
(3044927) Protein electrophoresis panel - Urine
17
64
2.69
3.41
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
101
704
1.50
3.36
2.1
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
95
2.35
3.36
3.4
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
197
1.92
3.35
1.6
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
11
32
3.47
3.34
2.5
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
128
2.15
3.33
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
70
450
1.61
3.33
5.6
4.2
%
0.1
0.1
0.12
19
138
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
25
116
2.19
3.25
2.1
3.5
u/ml
21.5
394.4
1.06
20
109
(3017181) Myelocytes/100 leukocytes in Blood
73
478
1.58
3.22
5.4
4.1
%
1.8
0.9
1.06
21
152
(3002179) Metamyelocytes/100 leukocytes in Blood
67
430
1.61
3.21
5.2
4.0
%
1.2
0.4
1.05
16
110
(3024928) Oxygen saturation in Venous blood
28
137
2.08
3.20
1.5
2.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
85
2.39
3.17
1.9
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
569
5218
1.33
3.15
25.0
15.9
%
36.6
39.2
4.94
367
3586
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
20
4.54
3.12
1.0
2.9
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
13
45
2.92
3.03
1.2
1.3
g/l
0.5
0.3
—
8
29
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
12
5.87
3.02
1.7
3.9
%
157.7
126.5
—
7
12
(3022806) Fractional oxyhemoglobin in Capillary blood
18
75
2.43
2.98
2.3
1.9
%
90.3
89.9
0.10
18
75
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
42
245
1.75
2.89
3.5
3.2
u/ml
2601.2
1381.4
0.19
37
209
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
77
524
1.52
2.89
2.4
3.0
ng/l
274.0
252.7
0.11
68
478
(3002619) Bacteria identified in Specimen by Culture
7
13
5.42
2.87
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
42
246
1.75
2.85
2.4
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
59
2.57
2.80
2.4
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
63
413
1.57
2.79
5.1
5.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
23
3.95
2.78
1.0
1.1
iu/ml
165.7
102.2
—
9
23
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
78
2.34
2.76
1.4
1.3
u/ml
284.2
285.6
0.01
12
44
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
6
8.38
2.75
1.0
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
118
2.07
2.74
4.6
2.4
%
16.3
15.9
0.26
12
58
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
132
2.00
2.73
1.4
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
48
2.74
2.73
1.3
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
105
2.13
2.71
1.6
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
105
2.13
2.71
4.0
3.4
%
58.0
57.9
0.01
22
105
(3000012) Reticulocyte production index
11
37
3.00
2.70
1.3
2.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
37
3.00
2.70
2.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
79
2.31
2.69
2.4
2.4
mg/l
26.2
25.7
—
9
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
59
385
1.58
2.68
1.9
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
24
3.78
2.68
1.2
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
43
259
1.70
2.66
4.0
6.6
%
1.7
1.5
0.46
43
245
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
93
2.18
2.63
1.3
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
610
5700
1.32
2.62
5.3
4.5
mmol/l
6.0
5.9
0.86
544
5120
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
100
2.13
2.61
3.0
3.0
e9/l
4.2
4.4
0.15
21
100
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
87
2.21
2.59
2.4
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
38
2.92
2.59
2.1
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
7
7.18
2.55
1.0
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
97
710
1.42
2.53
2.1
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
181
1.80
2.47
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
181
1.80
2.47
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
63
426
1.52
2.46
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
266
2266
1.26
2.44
5.3
4.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
182
1.79
2.43
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
83
2.20
2.42
1.4
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
12
5.03
2.40
1.3
1.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
12
5.03
2.40
1.3
1.1
mmol/l
-2.2
3.0
—
6
12
(1001926) Buprenorphine [Presence] in Urine by Screen method
20
97
2.09
2.39
2.1
1.2
—
—
—
0
0
(4146454)
12
46
2.63
2.36
2.6
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
151
1203
1.32
2.32
3.5
3.0
mmol/l
2.4
2.5
0.75
125
1045
(3021901) Oxygen saturation in Capillary blood
22
112
1.99
2.32
4.3
2.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
59
2.40
2.30
2.5
2.6
—
—
—
0
0
(4198724)
6
13
4.64
2.27
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
36
217
1.69
2.26
2.3
2.9
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
9
5.58
2.21
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
654
6212
1.32
2.20
15.9
10.1
u/l
24.4
24.5
0.05
632
5963
(3007461) Platelets [#/volume] in Blood
677
6464
1.35
2.19
36.8
21.6
e9/l
255.3
247.6
1.84
660
6280
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
186
1536
1.28
2.18
1.6
1.6
mmol/l
1.4
1.3
0.66
165
1278
(3024731) MCV [Entitic volume]
677
6465
1.35
2.17
36.7
21.5
fl
91.4
91.4
0.03
663
6348
(3035941) MCH [Entitic mass]
677
6466
1.35
2.16
36.6
21.4
pg
30.2
30.4
1.26
663
6348
(3026361) Erythrocytes [#/volume] in Blood
677
6467
1.35
2.15
36.8
21.6
e12/l
4.3
4.4
7.56
658
6265
(3010813) Leukocytes [#/volume] in Blood
677
6469
1.34
2.13
36.8
21.6
e9/l
7.0
6.8
1.52
659
6265
(3000963) Hemoglobin [Mass/volume] in Blood
677
6471
1.34
2.11
37.1
21.7
g/l
128.6
133.3
12.88
665
6350
(40760892) CBC W Ordered Manual Differential panel - Blood
153
1239
1.29
2.09
7.0
4.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
20
3.52
2.06
2.0
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
56
2.34
2.05
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
104
1.95
2.02
1.7
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
40
258
1.58
1.96
3.9
6.7
%
1.0
0.9
0.28
40
244
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
11
4.57
1.94
2.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
47
317
1.51
1.90
4.5
4.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
376
1.47
1.88
1.1
1.2
iu/ml
231.5
142.9
1.13
23
159
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
215
1.61
1.82
1.4
1.3
iu/l
28.0
28.8
0.04
29
190
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
296
1.52
1.81
16.5
10.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
73
2.08
1.81
1.1
3.5
—
2975.2
—
0
9
(3000093) Morphology [Interpretation] in Blood Narrative
12
53
2.28
1.81
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
188
1588
1.24
1.80
5.5
4.1
estimate
0.0
0.0
0.50
72
521
(3010503) CD19 cells [#/volume] in Blood
8
29
2.78
1.79
1.9
2.2
e9/l
0.1
0.1
—
8
29
(21494755) Public health laboratory ask at order entry panel
27
434
0.61
1.78
1.4
1.4
—
—
—
0
0
(4062490)
11
47
2.36
1.78
1.3
1.3
—
—
—
0
0
(3020891) Body temperature
36
233
1.57
1.76
6.7
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
74
2.05
1.76
1.1
1.1
—
—
—
0
0
(4010399)
57
409
1.42
1.72
1.3
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
55
2.20
1.68
1.3
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
134
1.74
1.67
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
134
1.74
1.67
2.0
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
134
1.74
1.67
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
157
1311
1.25
1.67
4.6
4.2
kg/l
1.0
1.0
0.10
27
189
(21494434) Karyotype in Bone marrow
13
62
2.12
1.66
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
90
1.91
1.66
2.8
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
69
2.05
1.65
1.7
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
25
2.82
1.65
1.4
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
76
1.99
1.65
1.5
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
164
1930
0.81
1.62
2.7
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
83
641
1.33
1.62
5.0
3.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
14
3.59
1.61
3.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
14
3.59
1.61
3.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
63
2.08
1.60
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
20
3.01
1.58
1.5
1.9
nmol/l
2.2
11.7
—
6
15
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
129
1.73
1.58
2.0
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
50
2.22
1.57
1.3
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
540
1.35
1.54
2.8
2.5
ug/l
3.9
6.9
2.57
59
469
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
44
2.29
1.53
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
44
2.29
1.53
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
44
2.29
1.53
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
51
2.17
1.51
1.2
1.3
—
—
—
0
0
(4094501)
22
131
1.70
1.51
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
6
21
2.87
1.51
1.8
1.8
nmol/l
0.5
1.0
—
6
16
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
45
2.24
1.47
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
45
2.24
1.47
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
45
2.24
1.47
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
94
750
1.29
1.46
8.9
7.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
38
2.38
1.46
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
80
1.89
1.45
2.4
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
406
1.38
1.44
4.1
3.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
16
3.14
1.44
1.6
2.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
16
3.14
1.44
1.6
2.3
%
6.8
4.7
—
5
16
(3014051) Protein [Presence] in Urine by Test strip
22
133
1.67
1.44
2.8
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
22
2.74
1.43
5.2
5.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
39
2.32
1.43
1.9
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
448
4171
1.17
1.42
4.6
3.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
96
1.79
1.40
2.1
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
67
1.96
1.39
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
119
1.70
1.39
2.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
215
1.51
1.37
1.6
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
23
2.62
1.37
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
42
2.16
1.34
1.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
90
1.79
1.34
2.9
2.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
53
396
1.36
1.31
7.9
7.6
mmol/l
23.7
24.4
0.84
53
375
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
14
76
1.86
1.30
1.1
1.3
—
0.5
—
0
5
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.6
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
130
1.63
1.28
2.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
55
2.01
1.28
2.1
2.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
44
2.06
1.27
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
44
2.06
1.27
1.2
1.8
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
35
2.30
1.27
1.3
1.1
u/l
13.8
17.1
—
8
29
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
77
1.83
1.26
1.1
1.3
nmol/l
0.6
0.6
0.04
14
70
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
92
1.75
1.25
2.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
131
1.62
1.24
2.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
21
131
1.62
1.24
2.6
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
25
2.41
1.24
1.5
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
36
2.23
1.24
1.3
1.1
u/l
55.6
73.5
—
8
31
(3017569) Oxygen content in Arterial blood
8
36
2.23
1.24
1.1
3.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
63
1.92
1.23
3.3
2.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
78
1.81
1.21
2.1
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
17
101
1.70
1.20
1.6
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
26
2.32
1.19
1.3
2.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
38
2.12
1.18
1.5
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
64
1.89
1.18
3.4
4.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
64
1.89
1.18
1.2
1.5
%
63.7
64.7
—
7
47
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
608
5842
1.18
1.17
5.2
4.9
mmol/l
2.5
2.7
7.75
551
5325
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
277
1.39
1.11
1.4
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
571
5468
1.16
1.11
4.3
3.9
mmol/l
1.3
1.2
2.11
520
4953
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
104
1.65
1.10
1.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
128
1.58
1.09
2.3
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
21
2.39
1.09
1.8
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
594
5710
1.17
1.07
4.8
4.4
mmol/l
4.4
4.6
7.28
550
5248
(3045142) Bone marrow Pathology biopsy report
12
67
1.80
1.05
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
75
1.75
1.03
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
182
1615
1.17
1.03
5.0
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
64
512
1.27
1.02
6.3
3.4
mmol/l
1.2
1.2
0.62
58
442
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
47
1.93
1.02
3.0
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
99
1.63
1.00
2.8
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
296
0.67
1.00
1.3
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
76
1.72
0.99
1.3
1.3
e6/l
1356.4
1180.7
—
8
52
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
175
0.57
0.99
1.8
1.4
—
—
—
0
0
(44790048)
11
61
1.81
0.98
1.5
1.7
—
—
—
0
0
(44790047)
11
61
1.81
0.98
1.5
1.7
—
—
—
0
0
(44806118)
11
61
1.81
0.98
1.5
1.7
—
—
—
0
0
(44790049)
11
61
1.81
0.98
1.5
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
84
1.68
0.98
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
15
92
1.64
0.97
1.2
1.4
g/l
35.2
31.6
0.67
15
79
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
69
1.75
0.97
1.2
1.2
e6/l
16231.2
50059.0
—
6
41
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
50
1.81
0.97
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
77
1.70
0.95
1.2
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
588
5667
1.15
0.95
4.8
4.3
mmol/l
1.4
1.5
3.03
537
5170
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
37
1.90
0.94
1.9
1.9
umol/l
13.7
14.1
—
7
32
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
150
1.48
0.93
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
505
4824
1.13
0.91
29.0
18.0
%
14.1
13.8
2.53
499
4713
(40761535) Cells panel - Urine sediment
61
494
1.25
0.90
4.8
3.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
63
1.76
0.90
2.6
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
29
2.08
0.89
1.5
1.2
—
—
—
0
0
(3000492) Spirometry study
62
504
1.25
0.89
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
71
1.70
0.89
1.2
1.1
u/ml
0.3
3.4
—
7
27
(3026389) Candida sp identified in Specimen by Organism specific culture
12
71
1.70
0.89
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
71
1.70
0.89
1.2
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
155
0.58
0.89
1.2
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
35
264
1.34
0.87
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
3.5
1.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
32
1.88
0.82
2.2
2.3
e6/l
206.7
487.1
—
6
27
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.82
3.5
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
122
1.49
0.80
2.2
2.1
u/l
12.2
4449.5
—
6
45
(3027456) Digoxin [Moles/volume] in Serum or Plasma
21
148
1.43
0.78
3.5
3.4
nmol/l
0.9
0.9
0.19
13
117
(3050129) First trimester maternal screen panel - Serum or Plasma
5
96
0.52
0.78
2.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
67
1.65
0.75
1.2
1.0
u/ml
1.2
4.1
—
5
31
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
83
1.58
0.75
2.2
1.6
—
—
—
0
0
(44806420)
5
24
2.09
0.74
2.2
2.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
24
2.09
0.74
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
142
1.42
0.73
2.0
1.7
iu/l
4.1
5.5
—
8
46
(3025130) Human papilloma virus identified in Specimen
10
60
1.68
0.72
1.2
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
192
0.67
0.68
1.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
61
1.65
0.68
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
69
1.60
0.68
1.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
43
1.63
0.67
1.3
1.4
%
10.8
11.0
—
7
43
(40768806) Pleura Pathology biopsy report
12
78
1.55
0.66
1.3
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
10
62
1.62
0.65
1.2
1.0
u/ml
0.1
0.8
—
5
24
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
269
1.28
0.65
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
2.1
u/ml
1941.0
787.2
—
5
29
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
435
0.80
0.63
1.5
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
104
1.45
0.63
1.0
1.2
—
—
—
0
0
(4035726)
61
518
1.19
0.62
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
86
753
1.16
0.61
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
166
1.33
0.59
1.6
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
25
193
1.31
0.58
6.2
3.7
mmol/l
3.9
3.9
0.24
25
178
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
35
1.72
0.57
1.0
1.2
ug/l
3.9
6.1
—
6
29
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
54
1.49
0.57
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
36
1.67
0.56
5.5
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
194
1.30
0.56
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
21
159
1.33
0.56
1.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
3.5
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
58
499
1.18
0.53
6.8
3.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
158
1455
1.11
0.53
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
152
1.32
0.52
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
63
1.43
0.52
1.6
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
65
1.39
0.50
1.2
1.2
%
120.8
117.9
—
9
60
(40768793) Breast Pathology biopsy report
11
154
0.71
0.47
1.5
1.3
—
—
—
0
0
(4268621)
7
49
1.43
0.46
3.0
2.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
31
1.62
0.43
8.0
14.7
—
—
—
0
0
(4281824)
8
57
1.41
0.42
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
57
1.41
0.42
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
41
351
1.18
0.42
1.5
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(4027681)
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
0.8
—
0
14
(3040151) Glucose [Moles/volume] in Capillary blood
9
67
1.35
0.38
2.4
11.4
mmol/l
6.0
7.0
—
9
53
(1761482) Bacteria [#/volume] in Urine by Culture
22
180
1.23
0.36
6.1
5.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
96
884
1.10
0.35
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
46
1.31
0.33
1.7
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.1
1.6
—
—
—
0
0
(4306422)
8
65
1.23
0.27
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
53
482
1.11
0.26
3.2
2.6
ml/min/173m2
60.3
65.0
0.39
35
210
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
72
0.69
0.26
1.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
46
416
1.11
0.25
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
38
1.32
0.23
1.6
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
2.0
1.5
g/l
0.8
0.9
—
5
38
(3044242) Glucose [Moles/volume] in Arterial blood
5
38
1.32
0.23
1.2
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
1068
0.94
0.22
2.9
3.1
ug/l
0.8
0.8
0.09
73
727
(3049717) Cytology report of Urine Cyto stain
30
267
1.13
0.22
2.1
3.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
9.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
13
0.00
0.21
0.0
1.5
—
1.2
—
0
13
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
49
1.23
0.20
2.0
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
52
1.16
0.19
1.3
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
70
0.71
0.16
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
70
0.71
0.16
1.8
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
68
1.18
0.16
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
69
1.16
0.16
1.3
1.3
nmol/l
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
256
0.90
0.16
1.9
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
14
121
1.16
0.15
1.5
1.6
e6/l
4255.9
144.2
—
9
100
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
14
121
1.16
0.15
1.4
1.5
e6/l
13.9
11.8
—
9
95
(3044941) Cell count panel - Synovial fluid
11
93
1.19
0.14
2.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
191
1861
1.03
0.14
5.4
5.3
ug/l
2.2
3.0
1.42
162
1631
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
315
1.08
0.13
2.2
2.2
nmol/l
11.5
12.5
0.22
28
279
(3021387) Prolactin [Units/volume] in Serum or Plasma
17
151
1.13
0.13
2.0
1.6
mu/l
243.9
281.9
0.51
17
135
(4034850)
21
191
1.10
0.12
7.9
10.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
145
1.11
0.09
2.1
1.6
e6/l
18780.0
13723.1
—
10
106
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
165
1.09
0.08
1.8
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
65
1.08
0.08
1.3
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
581
0.96
0.08
1.6
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
68
1.03
0.08
5.4
3.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
74
0.81
0.07
2.5
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
143
0.91
0.07
1.7
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
83
0.84
0.07
1.9
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
83
0.84
0.07
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
83
0.84
0.07
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
83
0.84
0.07
1.9
1.4
—
—
—
0
0
(1002224) Polysomnography panel
21
200
1.05
0.03
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
487
4889
0.99
0.03
30.4
19.3
g/l
329.4
331.6
4.92
480
4836
(3039000) Anion gap in Blood
13
139
0.93
0.03
7.5
9.5
mmol/l
11.9
11.4
0.31
13
128
(3018572) Chloride [Moles/volume] in Blood
13
139
0.93
0.03
7.5
9.5
mmol/l
104.8
105.2
0.09
13
128
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
150
1489
1.01
0.02
4.5
4.6
%
21.0
21.7
0.18
69
753
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
0.2
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
60.6
—
0
7
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
89
1.01
0.00
1.4
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
67
0.89
0.00
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
87
0.92
0.00
1.6
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
53
0.94
0.00
1.4
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
53.4
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_VIT_B_DEF and mortality.

Females

Parameter HR [95% CI] p-value
E4_VIT_B_DEF 1.558 [1.34, 1.81] < 0.001
Birth year 0.995 [0.99, 1.0] 0.248

During the follow-up period (1.1.1998 — 31.12.2019), 919 out of 2076 females with E4_VIT_B_DEF died.

Males

Parameter HR [95% CI] p-value
E4_VIT_B_DEF 1.736 [1.45, 2.08] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 800 out of 1606 males with E4_VIT_B_DEF died.

Mortality risk

Mortality risk for people of age

years, who have E4_VIT_B_DEF.

N-year risk Females Males
1 0.131% 0.299%
5 0.919% 1.861%
10 2.566% 4.57%
15 4.72% 8.204%
20 8.144% 13.297%

Relationships between endpoints

↥

Index endpoint: E4_VIT_B_DEF – Deficiency of other B group vitamins

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data